The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 19, 2022

Filed:

Apr. 23, 2020
Applicant:

Harbin Medical University, Harbin, CN;

Inventors:

Xilin Sun, Harbin, CN;

Lina Wu, Harbin, CN;

Jie Yang, Harbin, CN;

Kai Wang, Harbin, CN;

Lili Yang, Harbin, CN;

Haoxiang Li, Harbin, CN;

Yingbo Li, Harbin, CN;

Xiaona Li, Harbin, CN;

Shuang Liu, Harbin, CN;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 49/00 (2006.01); A61K 49/18 (2006.01); A61K 9/51 (2006.01);
U.S. Cl.
CPC ...
A61K 49/0093 (2013.01); A61K 9/5123 (2013.01); A61K 49/0002 (2013.01); A61K 49/0041 (2013.01); A61K 49/1824 (2013.01);
Abstract

The present invention provides aF-MR/fluorescence multi-mode molecular imaging and drug loading diagnosis-treatment integrated nanoprobe, and a preparation method and an application. The nano-probe is a nanoparticle formed by coating a mixture of a surfactant containing a molecular targeting treatment drug and a fluorescent dye with a Perfluorocarbon (PFC) carrier; and by uniformly dispersing a mixed solution into water and glycerol, processing ultrasonically, removing a component which is not effectively coated, and purifying, the drug-loading nanoparticle capable of being used for 19 F-MR imaging may be prepared. The nano-probe may implement in-vivo 19F-MR molecular imaging; a carried molecular targeting treatment drug can implement targeted binding and targeted treatment; and by virtue of a characteristic that PFC in a nucleus may carry and release oxygen massively, an anaerobious microenvironment in the tumor is improved, a chemosensitization effect is achieved, and thus the diagnosis-treatment integration of the tumor is implemented finally.


Find Patent Forward Citations

Sun, Xilin. (2022). Diagnosis-treatment integrated nano-probe forf-mr/fluorescence multi-mode molecular imaging and drug-loading and preparation method and application of nano-probe (U.S. Patent No. 11389549). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11389549

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…